[ Rapid Medical raises $9M in Series B ]
Rapid Medical has raised $9 million in Series B funding.
Founded in 2008, Rapid Medical is developing game-changing devices for endovascular treatments. Rapid Medical is the maker of TIGERTRIEVER, the first-ever controllable, fully visible stentriever that is designed to treat ischemic stroke patients
The new financing will be used to advance the commercialization of the company’s minimally invasive stroke treatment and prevention products, the TIGERTRIEVER Revascularization Device, and the COMANECI, Adjustable Remodeling Mesh.
|Founder / CEO||Ronen Eckhouse|
|Investors||Shanghai-Israel Investment Fund|